Categorie
-
Adhesives
5
Amines
93
Amino Acids
180
Analytical Reagents
664
Antibiotics
251
Bioactive Small Molecules
717
Aroma Chemicals
203
Biochemicals
1004
Boronic Acids
4
Buffers
97
Building Blocks
1770
Carbohydrates
176
Catalysts
97
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
250
Flavours and Fragrance Materials
202
Fluorinated Products
42
Furans
5
Gases in Solution
49
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
79
Organics
1294
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
97
Research Organics & Inorganics
749
Salts
282
Sealing Compounds
1
Sherclin
2
Solvents
121
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
150
Water Analysis
10
Cefdinir
(64816621 | 91832-40-5)
CAS: | 91832-40-5 |
---|---|
Formula molecolare: | C14H13N5O5S2 |
Peso molecolare: | 395.41 |
Disponibilità: | In stock |
---|---|
Downloads: | | |
64816621-100mg | 100mg | £108.90 | |
Ordine all'ingrosso |
64816621-100mg | 100mg | €152.50 | |
Ordine all'ingrosso |
64816621-100mg | 100mg | $163.40 | |
Ordine all'ingrosso |
Scheda di sicurezza
Certificato di analisi
Dettagli del prodotto
Product Code | 64816621 | ||||
Product Name | Cefdinir | ||||
Categories | Antibiotics Bioactive Small Molecules | ||||
CAS | 91832-40-5 | ||||
Molecular Formula | C14H13N5O5S2 | ||||
Molecular Weight | 395.41 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2941900000 |
Specifiche del prodotto
Physical Appearance | White to light yellow crystalline powder | ||||
Specific rotation | -58°- -66 ° | ||||
Heavy metals | 10ppm max | ||||
Acetonitrile | 0.041% max | ||||
Water Content | 2.0% max | ||||
Assay | >94% (anhydrous) | ||||
Related Substances | 3.0% max | ||||
Absorption | 570-610(287nm) |
Informazioni sulla sicurezza
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|